Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study

Quartier, Pierre; Alexeeva, Ekaterina; Constantin, Tamas; Chasnyk, Vyacheslav; Wulffraat, Nico; Palmblad, Karin; Wouters, Carine; Brunner, Hermine; Marzan, Katherine; Schneider, Rayfel; Horneff, Gerd; Martini, Alberto; Anton, Jordi; Wei, Xiaoling; Slade, Alan; Ruperto, Nicolino; Abrams, ÖZGÜR

doi:10.1002/art.41488

Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study

Quartier P., Alexeeva E., Constantin T., Chasnyk V., Wulffraat N., Palmblad K., ...Daha Fazla

ARTHRITIS & RHEUMATOLOGY, cilt.73, ss.336-346, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 73
Basım Tarihi: 2021
Doi Numarası: 10.1002/art.41488
Dergi Adı: ARTHRITIS & RHEUMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE
Sayfa Sayıları: ss.336-346
İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Objective To evaluate the efficacy and safety of 2 canakinumab monotherapy tapering regimens in order to maintain complete clinical remission in children with systemic juvenile idiopathic arthritis (JIA).